These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3664531)

  • 1. Antibody-dependent cell-mediated cytotoxicity using a murine monoclonal antibody against human colorectal cancer in cancer patients.
    Takamuku K; Akiyoshi T; Tsuji H
    Cancer Immunol Immunother; 1987; 25(2):137-40. PubMed ID: 3664531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
    Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatment.
    Frödin JE; Pihlstedt P; Lefvert AK; Mellstedt H
    Hybridoma; 1987 Dec; 6(6):555-64. PubMed ID: 3325401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
    Pendurthi TK; Parker R; Schlom J; Primus FJ
    Int J Cancer; 1990 Dec; 46(6):1021-8. PubMed ID: 2123477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.
    Abdullah N; Greenman J; Pimenidou A; Topping KP; Monson JR
    Cancer Immunol Immunother; 1999 Dec; 48(9):517-24. PubMed ID: 10602889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
    Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
    Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
    J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes.
    Ottonello L; Morone P; Dapino P; Dallegri F
    Blood; 1996 Jun; 87(12):5171-8. PubMed ID: 8652830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
    Rosales C; Jeglum KA; Obrocka M; Steplewski Z
    Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
    Christiaansen JE; Sears DW
    Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody dependent cell mediated cytotoxicity on human cervical carcinoma cell line, ME-180, with human monoclonal antibody.
    Osumi K; Nagao J; Yuasa H; Fujimoto H; Hagiwara H; Kodera Y; Ohno R
    Cancer Lett; 1992 Feb; 62(2):179-83. PubMed ID: 1540945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells.
    Tsang KY; Finch MD; Primus FJ; Schlom J
    Cancer Immunol Immunother; 1991; 34(1):9-16. PubMed ID: 1836975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.